November 27, 2012 – In July, Bloomberg News reported that German drug maker Bayer had committed over $600 million to settle Yaz lawsuits, but it was unclear how long the current stream of settlements would continue.
Now, the latest financial report from the company indicates that only a fraction of the cases have been resolved and settlements may go well into next year.
This is promising news for anyone affected by blood clots after taking Yaz or Yasmin who has not filed a claim yet.
According to Bayer’s Interim Financial Statement issued on September 30, 2012, the company has now set aside more than $260 million to settle additional Yaz lawsuits. However, they are only settling claims involving blood clot injuries like deep vein thrombosis, stroke and pulmonary embolism.
Anyone who suffered a blood clot, DVT, stroke or Pulmonary Embolism after taking Yaz or Yasmin should speak with a lawyer about their legal options.
Bayer also informed investors that they have settled around 3,500 Yaz cases so far for more than $750 million, at an average of approximately $214,000 per case. This is slightly higher than the average value last reported in July.
The news comes as the American College of Obstetricians and Gynecologists last month renewed warnings that birth control pills containing drospirenone such as Yaz and Yasmin may have a higher risk of causing blood clots.
The FDA also released a study in October of 2011 which found drugs like Yaz could increase the risk of blood clots, DVT and pulmonary embolism as much as 74%.
Due to the number of victims, Yaz cases have been consolidated into a federal Multi-District Litigation court in Illinois. Amid mounting safety warnings, Judge Herndon ordered the parties to enter into negotiations.
The funding for additional Yaz settlements is positive for anyone who was injured by the drug and has not yet filed a claim. However, time is limited and only certain cases may qualify.
Anyone affected is urged to contact the Drug Risk Resource Center or speak with a lawyer about their legal options. However, you should seek a lawyer with experience in defective drug litigation.
The DrugRisk center only recommends lawyers and law firms who have already settled Yaz lawsuits.
For more information on the research, side effects and litigation news related to Yaz and other drugs, or to speak with a lawyer, contact us today.